Wilson Sonsini Goodrich & Rosati advised Ripple on the transaction. Ripple Therapeutics Corporation (Ripple) announced a collaboration and option-to-license agreement with AbbVie to develop RTC-620, a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Circle Pharma in the transaction. Circle Pharma, a clinical-stage biopharmaceutical company, announced the closing of a $90 million Series D...
You must be a Standard 1 Year member to access this content.
Taft Stettinius & Hollister advised ONL Therapeutics on the transaction, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters. ONL Therapeutics, Inc. announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Neo Medical on U.S. aspects of the financing. Neo Medical SA (Neo), a Swiss technology company specializing in spine surgery,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Strider Technologies, Inc. on the transaction. Strider Technologies, Inc., a leading provider of strategic intelligence, announced that it has closed...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Cellino Biotech, Inc. on the transaction. Cellino Biotech, Inc. (Cellino) announced that the Advanced Research Projects Agency for Health (ARPA-H),...
You must be a Standard 1 Year member to access this content.
Sidley Austin is representing Battea-Class Action Services in the transaction, and Davis Polk & Wardwell is representing SS&C Technologies Holdings, Inc. SS&C Technologies Holdings, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Sidley Austin is advising Mastercard on the transaction, and Willkie Farr & Gallagher is advising Recorded Future. Wilson Sonsini Goodrich & Rosati is advising Mastercard on...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised SpectraWAVE on the transaction. SpectraWAVE, Inc., a medical imaging company, has announced raising $50 million in Series B funding round...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Syxsense on the transaction. Absolute Security, announced it acquired Syxsense, a provider of automated endpoint and vulnerability management. Financial terms...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised JP Morgan Life Sciences Private Capital on the transaction. Pathalys Pharma, Inc., a private biopharmaceutical company in the late stages...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised eGenesis on the transaction. eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, announced the...
You must be a Standard 1 Year member to access this content.
